
Nuvista Pharmaceuticals Private Limited
About Nuvista Pharmaceuticals Private Limited
Data last updated:
Nuvista Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC115996. Its GSTIN is 36AAFCN5519F1ZH (Telangana).
The company has an authorised share capital of ₹1.9 Cr and a paid-up capital of ₹1.9 Cr. It is led by directors including Surya Rao Yechuri (Managing Director) and Masaram Venkataiah Goud.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No 48 Phase II Ida Mallapur, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.25 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹7.81 Lakh (net margin 0.8%) and EBITDA of ₹15.81 Lakh (EBITDA margin 1.5%).
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nuvista Pharma. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹95 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nuvista Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShed No 48 Phase II Ida Mallapur, Hyderabad, Telangana, India – 500076
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nuvista Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nuvista Pharmaceuticals operates one associated brand: Nuvista Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are researched and manufactured through focused R&D efforts. | nuvistapharma.com |
Financials of Nuvista Pharmaceuticals Private Limited
FY 2025 filings availableNuvista Pharmaceuticals Private Limited reported revenue of ₹10.25 Cr (up 4% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year. EBITDA fell 53% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹10.25 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nuvista Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nuvista Pharmaceuticals Private Limited
Nuvista Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Masaram Venkataiah Goud | Director | 20 Mar 2017 | 9 Years 8 Months | Current |
| Surya Rao Yechuri | Managing Director | 20 Mar 2017 | 9 Years 8 Months | Current |
| Sudhakara Reddy Kalakota | Director | 17 Sep 2021 | 5 Years 2 Months | Current |
| Kallam Srikantha Reddy | Director | 20 Mar 2017 | 9 Years 8 Months | Current |
| Jakkajangreddy | Director | 18 May 2017 | 9 Years 6 Months | Current |
Auditor
Nuvista Pharmaceuticals Private Limited is audited by k bhargava ramanjaneya for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| k bhargava ramanjaneya | FY 2023 | 227372 |
Shareholding
The shareholding of Nuvista Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nuvista Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2024 | 100889675 | Others | ₹50 Lakh | Open | |
| 21 Aug 2018 | 100202194 | Others | ₹95 Lakh | Satisfied |
To see the full charge records of Nuvista Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Nuvista Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by State of Telangana.Drugs Inspector | Pending |
| District court, Vikarabad, Telangana | Criminal complaint | Filed against the company by State of Telangana Represented by the Drugs Inspector, Vikarabad District | Pending |
| District court, Guntur, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Nuvista Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nuvista Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 60 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bio-Leo Analytical Labs India Private Limited | |||
| Nuvista Pharmaceuticals Private Limited | |||
| Rite-Aid Labs Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Nuvista Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Nuvista Pharmaceuticals Private Limited has a workforce of 24 employees on its EPFO records as of Nov 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 24 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Nuvista Pharmaceuticals Private Limited, buy the company report.
GST
Nuvista Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCN5519F1ZH | Telangana | Active | 12 Sep 2017 |
To see the full GST registrations and return filing status of Nuvista Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nuvista Pharmaceuticals Private Limited has 7 board changes on record since 2017: 5 appointments and 2 cessations. The latest: Sudhakara Reddy Kalakota was appointed as Director on 17 Sep 2021.
1 earlier event is in the company report.
Frequently asked questions
Nuvista Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2017 (9+ years old) and is registered under CIN U24304TG2017PTC115996.
Nuvista Pharmaceuticals has 5 current directors:
- Surya Rao Yechuri - Managing Director
- Masaram Venkataiah Goud - Director
- Sudhakara Reddy Kalakota - Director
- Kallam Srikantha Reddy - Director
- Jakkajangreddy - Director
The latest financial statements of Nuvista Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Nuvista Pharmaceuticals is 36AAFCN5519F1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Nuvista Pharmaceuticals is U24304TG2017PTC115996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuvista Pharmaceuticals has 3 court cases on record: 3 filed against it. 3 are pending.
Nuvista Pharmaceuticals was incorporated on 20 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sudhakara Reddy Kalakota was appointed as Director on 17 Sep 2021. Manjula Kotha ceased to be Director on 31 Mar 2019. Saira Siddiqui ceased to be Director on 28 Jul 2018. Nuvista Pharmaceuticals has 7 board changes on record in total.
Nuvista Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 60 overdue payments to 14 micro and small suppliers. The latest return was filed on 08 Jun 2019.
The registered office of Nuvista Pharmaceuticals is at Shed No 48 Phase II Ida Mallapur, Hyderabad, Telangana, India – 500076.
Nuvista Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

